Munich, DE– The German app company, SmartPatient, who developed the health app MyTherapy for iOS and Android, conducted deep research into pharma mobile application usage and content. What they found was not on par with how we view our always-on digitally connected lives.

Their research revealed that many of the pharma apps that live in the app store have zero user reviews, are rarely updated, and typically only serve one or two functions.

Interestingly, what they did uncover was that the top pharma apps are not focused around chronic conditions, but on strategies and tools for everyday wellbeing and health management. Amongst those were pill reminder tools, quick workout apps, and gamified health apps.

The death of the pharma app may be a little quick on the trigger. But this research exposes where we should be focusing our attention and even more, where we shouldn’t.


About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.